Publication Date | Title | Author(s) |
2019 | Computational Fluid Dynamics Simulations of Membrane and Resin-based Chromatography | Umatheva, Umatheny |
3-Apr-2018 | Consecutive spray drying to produce coated dry powder vaccines suitable for oral administration | Le Clair, Daniel; Cranston, Emily; Lichty, Brian; Xing, Zhou; Thompson, Michael |
Jan-2021 | COVID-19 living evidence profile #1 (version 1.2): What is known about anticipated COVID-19 vaccine roll-out elements? | Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Sharma, K; Whitelaw, S; Lavis, JN |
Feb-2021 | COVID-19 living evidence profile #1 (version 1.3): What is known about anticipated COVID-19 vaccine roll-out elements? | Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Sharma, K; Whitelaw, S; Lavis, JN |
Feb-2021 | COVID-19 living evidence profile #1 (version 1.4): What is known about anticipated COVID-19 vaccine roll-out elements? | Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Sharma, K; Whitelaw, S; Lavis, JN |
Mar-2021 | COVID-19 living evidence profile #1 (version 1.5): What is known about anticipated COVID-19 vaccine roll-out elements? | Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Sharma, K; Whitelaw, S; Lavis, JN |
Apr-2021 | COVID-19 living evidence profile #1 (version 1.6): What is known about anticipated COVID-19 vaccine roll-out elements? | Bhuiya, AR; Bain, T; Wang, Q; Al-Khateeb, S; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Rintjema, J; Sharma, K; Santesso, N; Lavis, JN; Wilson, MG |
May-2021 | COVID-19 living evidence profile #1 (version 1.7): What is known about anticipated COVID-19 vaccine roll-out elements? | Bhuiya, AR; Bain, T; Wang, Q; Al-Khateeb, S; DeMaio, P; Ahmad, A; Drakos, A; Rintjema, J; Sharma, K; Matthews, M; Gauvin, François-Pierre; Lavis, JN; Wilson, MG |
Oct-2020 | COVID-19 rapid evidence profile #22: What is known about whether vaccine injury-compensation programs and program elements affect vaccine acceptance and uptake? | Bhuiya, AR; Waddell, K; Moat, KA; Wilson, MG; Gauvin, François-Pierre; Whitelaw, S; Alam, S; Sharma, K; Drakos, A; Lavis, JN |
Nov-2020 | COVID-19 rapid evidence profile #24: What is known about strategies for encouraging vaccine acceptance and addressing vaccine hesitancy (including efforts to combat misinformation that may lead to vaccine hesitancy) or uptake (when interpreted, at least in part, through the perspective of vaccine acceptance or hesitancy)? | Gauvin, François-Pierre; Lavis, JN |
2023 | Design considerations for intratracheal delivery devices to achieve proof-of-concept dry powder biopharmaceutical delivery in mice | Manser, Myla; Jeyanathan, Vidthiya; Jeyanathan, Mangalakumari; Feng, Xueya; Dolovich, Myrna; Xing, Zhou; Cranston, Emily; Thompson, Michael |
1-Jun-2023 | Internal microstructure of spray dried particles affects viral vector activity in dry vaccines | Singh, Varsha; Morgan, Blair; Schertel, Andre; Dolovich, Myrna; Xing, Zhou; Thompson, Michael; Cranston, Emily |
2024 | Introducing Cell Cycle Regulation to a Mathematical Model of the T-cell Proliferative Phase | Bhartt, Taran |
Mar-2024 | Profil de données probantes rapide 68 : Recenser les approches ou les programmes d’administration des vaccins et leur incidence sur l’adoption des vaccins | Bain, T; Dass, R; Ali, A; Alam, S; Jaspal, A; Phelps, A; Wilson, MG |
Mar-2024 | Rapid evidence profile #68: Identifying vaccine delivery approaches or programs and their impact on vaccine uptake | Bain, T; Dass, R; Ali, A; Alam, S; Jaspal, A; Phelps, A; Wilson, MG |
2024 | REPORTING OF HEALTH EQUITY CONSIDERATIONS IN VACCINE TRIALS FOR COVID-19: A METHODOLOGICAL REVIEW | Kou, Roger |
Oct-2012 | Targeting gp41 as a strategy to induce mucosal and humoral immunity against HIV-1 | Jain, Sumiti |
26-Apr-2018 | Thermal stability of spray dried vaccine powders encapsulating enveloped and non-enveloped viral vectors | Toniolo, Steven |
2016 | Thermally Stable Human Type 5 Adenovirus through Spray Drying: Storage Efficacy and Process Optimization | LeClair, Daniel |